Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Generation Bio Co. (GBIO)

Generation Bio Co. (GBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Generation Bio Announces Third Quarter 2025 Financial Results

CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results. Third Quarter 2025 Financial Results...

GBIO : 5.33 (+2.11%)
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey Jonas...

GBIO : 5.33 (+2.11%)
CMPS : 5.82 (+2.46%)
Generation Bio Announces CEO Transition

• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President ...

GBIO : 5.33 (+2.11%)
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results

• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown...

GBIO : 5.33 (+2.11%)
Generation Bio Announces 1-for-10 Reverse Stock Split

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases,...

GBIO : 5.33 (+2.11%)
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GBIO : 5.33 (+2.11%)
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

GBIO : 5.33 (+2.11%)
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

GBIO : 5.33 (+2.11%)
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

GBIO : 5.33 (+2.11%)
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

GBIO : 5.33 (+2.11%)

Barchart Exclusives

The Saturday Spread: 3 Stocks Flashing High-Probability Trading Setups to Consider This Week
Because market behaviors respond and adapt to new information, by measuring these fluctuations, we can gain a serious edge against every other trader. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar